Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 4/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31590688 | 0.88 | EPHX1 (0.38) | ALDH1A1MAPTTP53CYP1A2KDM4E | |
| SCHEMBL32670843 | 0.77 | CYP19A1 (0.40) | ALDH1A1MAPTLMNACYP1A2CYP3A4 | |
| SCHEMBL296804 | 0.71 | SLC6A2 (0.38) | SLC6A3 | |
| SCHEMBL1354899 | 0.71 | ALDH1A1 (0.36) | ALDH1A1MAPTLMNATSHRKDM4E | |
| SCHEMBL16116061 | 0.71 | LMNA (0.33) | ALDH1A1MAPTLMNAMAPK1TP53 | |
| SCHEMBL30608092 | 0.71 | CA2 (0.40) | ALDH1A1MAPTLMNAMAPK1TP53 | |
| SCHEMBL6288864 | 0.70 | MAPK1 (0.43) | ALDH1A1MAPTLMNAMAPK1TP53 | |
| SCHEMBL9694499 | 0.69 | MEN1 (0.45) | ALDH1A1MAPTHTR2BCA2KDM4E | |
| SCHEMBL17923887 | 0.67 | SIRT1 (0.37) | ALDH1A1MAPTLMNAMAPK1TP53 | |
| SCHEMBL8701734 | 0.65 | HRH1 (0.36) | GAATSHRSLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120081784-A | Whitening compound containing pyridine amide structure and preparation method and application thereof | 东北农业大学 | 2025-06-03 | — | — | CN | disclosed |
| CN-115851636-B | Mutant PDS polypeptide and application thereof | 山东舜丰生物科技有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-118599783-A | Hybridoma cell strain secreting furbenone monoclonal antibody and application thereof | 江南大学 | 2024-09-06 | — | — | CN | disclosed |
| CN-117448102-A | Preparation method of soybean paste flavored soy sauce wine | 张仲安 | 2024-01-26 | — | — | CN | disclosed |
| CN-115851636-A | Mutant PDS polypeptide and application thereof | 山东舜丰生物科技有限公司 | 2023-03-28 | — | — | CN | disclosed |
| US-20150208645-A1 | PHYTOSANITARY COMPOSITIONS COMPRISING AN ETHER-AMIDE COMPOUND | RHODIA OPERATIONS (FR) | 2015-07-30 | — | — | US | disclosed |
| EP-1594438-B1 | Use of an inhibitor of 15-hydroxyprostaglandin dehydrogenase in order to stimulate pigmentation of the skin or hair | OREAL (FR) | 2013-07-17 | — | — | EP | disclosed |
| US-7994176-B2 | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 | ELI LILLY AND COMPANY (US) | 2011-08-09 | — | — | US | disclosed |
| EP-2021337-B1 | INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 | LILLY CO ELI (US) | 2010-01-13 | — | — | EP | disclosed |
| CN-100486573-C | Nitrocessed and nitrosylated cyclooxygenase-2 inhibitors, compositions, and uses thereof | NITROMED INC (US) | 2009-05-13 | — | — | CN | disclosed |
| CN-1434712-A | Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use | NITROMED INC (US) | 2003-08-06 | — | — | CN | disclosed |
| US-6011060-A | TREATING A DISEASE MEDIATED BY ACTIVATION OF THE TUMOR NECROSIS FACTOR | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-01-04 | — | — | US | disclosed |
| US-6011060-A | TREATING A DISEASE MEDIATED BY ACTIVATION OF THE TUMOR NECROSIS FACTOR | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-01-04 | — | — | US | disclosed |
| US-6011060-A | TREATING A DISEASE MEDIATED BY ACTIVATION OF THE TUMOR NECROSIS FACTOR | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-01-04 | — | — | US | disclosed |
| EP-0900212-A1 | CHIRAL PHENYLDIHYDROFURANONES AS PDE-IV INHIBITORS | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-03-10 | — | — | EP | disclosed |
| WO-1997040032-A1 | CHIRAL PHENYLDIHYDROFURANONES AS PDE-IV INHIBITORS | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-10-30 | — | — | WO | disclosed |
| US-5422247-A | A grampositive or mutants of BLAKESLEA TRISPORA forming a mated culture product with gramnegative BLAKESLEA TRISPORA | UNIVERSAL FOODS CORPORATION (US) | 1995-06-06 | — | — | US | disclosed |
| US-5360730-A | Zeaxanthin producing strains of Neospongiococcum Excentricum | UNIVERSAL FOODS CORPORATION (US) | 1994-11-01 | — | — | US | disclosed |
| US-5328845-A | Fungal negative microorganism capable of producing high levels of beta-carotene | UNIVERSAL FOODS CORPORATION (US) | 1994-07-12 | — | — | US | disclosed |
| WO-1993020183-A1 | METHOD FOR PRODUCING BETA-CAROTENE USING A FUNGAL MATED CULTURE | UNIVERSAL FOODS CORPORATION (US) | 1993-10-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150208645-A1 | PHYTOSANITARY COMPOSITIONS COMPRISING AN ETHER-AMIDE COMPOUND | ACER2, LSS, FNTA | ALDH1A1 4758/4885MAPT 63/4885LMNA 795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.